Helptext

Movies



Company Information

Company NameEurocine Vaccines AB
Company Idea

Eurocine Vaccines is a publicly listed, clinical-stage company developing nasal vaccines that meet important medical needs. The vaccines are developed up to proof of concept (clinical phase I/II) and licensed to partners for further development and commercialization. The company's proprietary vaccine adjuvant technologies, which are a key element of the nasal vaccines, are also offered to license partners for development in various indications.

Present focus is on partnering the nasal influenza vaccine program, Immunose™ FLU, which has shown proof of concept in a clinical study, and on preclinical development of a nasal vaccine against bacterial pneumonia.

Phone070-634 0171CEOHans Arwidsson
E-mailinfo(snabel-a)eurocine-vaccines(punkt)comChairm. of the BoardMichael Wolff Jensen
Homepagehttp://www.eurocine-vaccines.com 

Instrument Information

Full NameEurocine VaccinesShort NameEUCI
No of shares53,458,721Par Value0.11 SEK
TypeShareISIN codeSE0001839069

Price Information

+/-(0.06)
%-1.33
Latest4.45
High4.59
Low4.36
Volume206,392
Turnover (SEK)920,145
Market Cap (MSEK)238

Orders

VolumeBidAskVolume

Deals

TimeBuyerSellerPriceVolume
4:45 PMSHBNON4.459,452
4:45 PMSHBAVA4.455,548
4:45 PMNONAVA4.45100
4:31 PMSHBNON4.457,500
4:31 PMNONNON4.469,899
4:29 PMNONNON4.46101
4:29 PMAVANON4.47499
4:29 PMSHBNON4.481,000
4:29 PMSHBNON4.48400
4:21 PMAVAMLI4.515,450

Scheduled Reports

DateReport
2017-05-18Delårsrapport tre




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se